| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Talis Biomedical Corporation (NASDAQ: TLIS)
TLIS Technical Analysis
5
| As on 1st Jan 2026 TLIS STOCK Price closed @ 2.84 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.38 & Strong Buy for SHORT-TERM with Stoploss of 1.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TLISSTOCK Price
| Open | 1.60 | Change | Price | % |
| High | 2.84 | 1 Day | 1.24 | 77.50 |
| Low | 1.60 | 1 Week | 1.24 | 77.50 |
| Close | 2.84 | 1 Month | 1.34 | 89.33 |
| Volume | 1677 | 1 Year | 1.23 | 76.40 |
| 52 Week High 2.84 | 52 Week Low 1.35 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 185.04 | -2.15% |
| OCG | 0.02 | 0.00% |
| ONDS | 14.01 | 15.02% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| SXTC | 1.25 | -37.50% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TLIS Daily Charts |
TLIS Intraday Charts |
Whats New @ Bazaartrend |
TLIS Free Analysis |
|
|
TLIS Important Levels Intraday
| RESISTANCE | 5.23 |
| RESISTANCE | 4.46 |
| RESISTANCE | 3.99 |
| RESISTANCE | 3.52 |
| SUPPORT | 2.16 |
| SUPPORT | 1.69 |
| SUPPORT | 1.22 |
| SUPPORT | 0.45 |
TLIS Forecast January 2026
| 4th UP Forecast | 4.21 |
| 3rd UP Forecast | 3.77 |
| 2nd UP Forecast | 3.5 |
| 1st UP Forecast | 3.23 |
| 1st DOWN Forecast | 2.45 |
| 2nd DOWN Forecast | 2.18 |
| 3rd DOWN Forecast | 1.91 |
| 4th DOWN Forecast | 1.47 |
TLIS Weekly Forecast
| 4th UP Forecast | 4.21 |
| 3rd UP Forecast | 3.77 |
| 2nd UP Forecast | 3.50 |
| 1st UP Forecast | 3.23 |
| 1st DOWN Forecast | 2.45 |
| 2nd DOWN Forecast | 2.18 |
| 3rd DOWN Forecast | 1.91 |
| 4th DOWN Forecast | 1.47 |
TLIS Forecast2026
| 4th UP Forecast | 6.31 |
| 3rd UP Forecast | 5.2 |
| 2nd UP Forecast | 4.51 |
| 1st UP Forecast | 3.82 |
| 1st DOWN Forecast | 1.86 |
| 2nd DOWN Forecast | 1.17 |
| 3rd DOWN Forecast | 0.48 |
| 4th DOWN Forecast | -0.63 |
Talis Biomedical Corporation ( NASDAQ USA Symbol : TLIS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TLIS Business Profile
Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. Address: 230 Constitution Drive, Menlo Park, CA, United States, 94025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service